Imagin Medical Inc. (IMEXF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2022 | -47.13 Thousand CAD | -60.38% |
| 2021 | -29.38 Thousand CAD | 8.67% |
| 2020 | -32.17 Thousand CAD | -31.32% |
| 2019 | -24.5 Thousand CAD | -75.24% |
| 2018 | -13.98 Thousand CAD | 1.8% |
| 2017 | -14.24 Thousand CAD | 2.1% |
| 2016 | -14.54 Thousand CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| 2008 | - CAD | 0.0% |
| 2007 | - CAD | 0.0% |
| 2006 | - CAD | 0.0% |
| 2005 | - CAD | -100.0% |
| 2004 | 646.00 CAD | -65.69% |
| 2003 | 1883.00 CAD | -8.5% |
| 2002 | 2058.00 CAD | 0.0% |
| 2001 | - CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q3 | -46.33 Thousand CAD | 0.0% |
| 2023 Q2 | -46.33 Thousand CAD | 0.0% |
| 2023 Q1 | -46.33 Thousand CAD | -91.59% |
| 2022 Q1 | -7650.00 CAD | -4.12% |
| 2022 FY | -47.13 Thousand CAD | -60.38% |
| 2022 Q4 | -24.18 Thousand CAD | -216.1% |
| 2022 Q3 | -7650.00 CAD | 0.0% |
| 2022 Q2 | - CAD | 100.0% |
| 2021 Q2 | -7346.00 CAD | 0.01% |
| 2021 Q1 | -7347.00 CAD | 50.54% |
| 2021 FY | -29.38 Thousand CAD | 8.67% |
| 2021 Q4 | -7347.00 CAD | 0.0% |
| 2021 Q3 | -7347.00 CAD | -0.01% |
| 2020 Q4 | -14.85 Thousand CAD | 0.0% |
| 2020 FY | -32.17 Thousand CAD | -31.32% |
| 2020 Q1 | - CAD | 0.0% |
| 2020 Q2 | - CAD | 0.0% |
| 2020 Q3 | - CAD | 0.0% |
| 2019 Q1 | - CAD | 0.0% |
| 2019 FY | -24.5 Thousand CAD | -75.24% |
| 2019 Q4 | - CAD | 0.0% |
| 2019 Q3 | - CAD | 0.0% |
| 2019 Q2 | - CAD | 0.0% |
| 2018 Q4 | - CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 FY | -13.98 Thousand CAD | 1.8% |
| 2018 Q2 | - CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 FY | -14.24 Thousand CAD | 2.1% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2016 FY | -14.54 Thousand CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2009 Q1 | - CAD | 0.0% |
| 2009 Q2 | - CAD | 0.0% |
| 2008 Q2 | - CAD | 0.0% |
| 2008 FY | - CAD | 0.0% |
| 2008 Q4 | - CAD | 0.0% |
| 2008 Q3 | - CAD | 0.0% |
| 2008 Q1 | - CAD | 0.0% |
| 2007 FY | - CAD | 0.0% |
| 2007 Q1 | - CAD | 0.0% |
| 2007 Q3 | - CAD | 0.0% |
| 2007 Q4 | - CAD | 0.0% |
| 2007 Q2 | - CAD | 0.0% |
| 2006 Q1 | - CAD | 0.0% |
| 2006 Q2 | - CAD | 0.0% |
| 2006 Q3 | - CAD | 0.0% |
| 2006 Q4 | - CAD | 0.0% |
| 2006 FY | - CAD | 0.0% |
| 2005 Q3 | - CAD | 0.0% |
| 2005 Q4 | - CAD | 0.0% |
| 2005 Q2 | - CAD | -100.0% |
| 2005 Q1 | 105.00 CAD | 118.75% |
| 2005 FY | - CAD | -100.0% |
| 2004 Q4 | 48.00 CAD | -43.53% |
| 2004 Q1 | 331.00 CAD | -27.57% |
| 2004 Q3 | 85.00 CAD | 0.0% |
| 2004 Q2 | - CAD | -100.0% |
| 2004 FY | 646.00 CAD | -65.69% |
| 2003 Q1 | 520.00 CAD | -14.05% |
| 2003 FY | 1883.00 CAD | -8.5% |
| 2003 Q2 | - CAD | -100.0% |
| 2003 Q4 | 457.00 CAD | -6.16% |
| 2003 Q3 | 487.00 CAD | 0.0% |
| 2002 Q3 | 300.00 CAD | 0.0% |
| 2002 Q4 | 605.00 CAD | 101.67% |
| 2002 FY | 2058.00 CAD | 0.0% |
| 2002 Q1 | - CAD | 0.0% |
| 2002 Q2 | - CAD | 0.0% |
| 2001 FY | - CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AVITA Medical, Inc. | 41.68 Million USD | 100.113% |
| Manhattan Scientifics, Inc. | -1000.00 USD | -4613.2% |
| Össur hf. | 485.57 Million USD | 100.01% |
| QHSLab, Inc. | 793.6 Thousand USD | 105.939% |
| Wellstar International, Inc. | - USD | Infinity% |
| Össur hf. | 485.57 Million USD | 100.01% |
| CVR Medical Corp. | - USD | Infinity% |
| Bionovate Technologies Corp | - USD | Infinity% |
| Escalon Medical Corp. | 5.14 Million USD | 100.916% |
| Aurora Spine Corporation | 8.21 Million USD | 100.574% |
| BrainsWay Ltd. | 23.09 Million USD | 100.204% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| BioElectronics Corporation | 466.38 Thousand USD | 110.106% |
| Hamilton Thorne Ltd. | 35.08 Million USD | 100.134% |
| Vivos Inc. | -6036.00 USD | -680.848% |
| Kelyniam Global, Inc. | 2.03 Million USD | 102.315% |
| REMSleep Holdings, Inc. | -756.73 Thousand USD | 93.772% |
| Zecotek Photonics Inc. | -195.32 Thousand USD | 75.869% |
| Avitar, Inc. | 836.7 Thousand USD | 105.633% |
| Nanomix Corporation | -69.45 Thousand USD | 32.143% |
| EKF Diagnostics Holdings plc | 16.74 Million USD | 100.281% |
| Theraclion SA | -1.08 Million USD | 95.637% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Positron Corporation | -353.46 Thousand USD | 86.666% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | 1.04 Million USD | 104.508% |
| Lombard Medical, Inc. | 955 Thousand USD | 104.935% |
| ALR Technologies Inc. | 4945.00 USD | 1053.124% |
| Stratec SE | 71.58 Million USD | 100.066% |
| Vycor Medical, Inc. | 1.31 Million USD | 103.582% |
| Heart Tronics, Inc. | - USD | Infinity% |
| MicroPort Scientific Corporation | 532.09 Million USD | 100.009% |
| VMS Rehab Systems, Inc. | -10.44 USD | -451355.939% |
| NewCardio, Inc. | 105.1 Thousand USD | 144.844% |
| Guided Therapeutics, Inc. | 36 Thousand USD | 230.922% |
| Ingen Technologies, Inc. | 268.57 Thousand USD | 117.549% |
| Odyssey Group International, Inc. | - USD | Infinity% |
| CYduct Diagnostics, Inc. | 56.59 Thousand USD | 183.281% |
| Wellness Center USA, Inc. | 587.55 Thousand USD | 108.022% |
| SANUWAVE Health, Inc. | 14.36 Million USD | 100.328% |
| IR-Med Inc. | -17 Thousand USD | -177.247% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | 122.833% |
| Polarean Imaging plc | 335.48 Thousand USD | 114.049% |
| United American Healthcare Corporation | -8000.00 USD | -489.15% |
| ECGI Holdings, Inc. | - USD | Infinity% |
| Nu-Med Plus, Inc. | -12.9 Thousand USD | -265.364% |
| Capital Group Holdings, Inc. | - USD | Infinity% |
| ADM Tronics Unlimited, Inc. | 1.09 Million USD | 104.308% |
| Medical Supply International USA, Inc. | 1.75 Million USD | 102.68% |
| Urologix, Inc. | 6.09 Million USD | 100.774% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | Infinity% |
| Nexeon MedSystems Inc. | -316.69 Thousand USD | 85.117% |
| SS Innovations International, Inc. | 713.44 Thousand USD | 106.606% |
| Qualis Innovations, Inc. | - USD | Infinity% |
| Smith & Nephew plc | 3.91 Billion USD | 100.001% |
| NIOX Group Plc | 28.13 Million USD | 100.168% |
| Fuse Medical, Inc. | 10.73 Million USD | 100.439% |
| Broncus Holding Corporation | 7.22 Million USD | 100.652% |
| Brain Scientific Inc. | 54.32 Thousand USD | 186.759% |
| Pressure BioSciences, Inc. | 799.56 Thousand USD | 105.895% |
| Health Logic Interactive Inc. | - USD | Infinity% |